CVS HEALTH Corp (CVS) stock
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3012% above fair value
$81.35−4.46 (-5.20%)
Close on Nov 18, 2026Market cap $104.04BP/E 21.6Yield 3.27%
Cvs Health gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Cvs Health's gross profit for the twelve months ending Jun 30, 2026 was $184.68B, up 6.5% year over year. For fiscal 2025 it was $180.90B, up 8.6% from the year before. Over ten years it grew 21.2% a year on average. The highest annual figure on record is $180.90B in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $180.90B | +8.6% |
| FY2024 | Dec 31, 2024 | $166.52B | +18.4% |
| FY2023 | Dec 31, 2023 | $140.68B | +12.0% |
| FY2022 | Dec 31, 2022 | $125.58B | +8.0% |
| FY2021 | Dec 31, 2021 | $116.31B | +11.1% |
| FY2020 | Dec 31, 2020 | $104.73B | +6.8% |
| FY2019 | Dec 31, 2019 | $98.06B | +157.2% |
| FY2018 | Dec 31, 2018 | $38.13B | +33.6% |
| FY2017 | Dec 31, 2017 | $28.55B | -1.1% |
| FY2016 | Dec 31, 2016 | $28.86B | +8.8% |
| FY2015 | Dec 31, 2015 | $26.53B | +4.6% |
| FY2014 | Dec 31, 2014 | $25.37B | +6.7% |
| FY2013 | Dec 31, 2013 | $23.78B | +5.8% |
| FY2012 | Dec 31, 2012 | $22.49B | +9.4% |
| FY2011 | Dec 31, 2011 | $20.56B | +1.7% |
| FY2010 | Dec 31, 2010 | $20.22B | -0.7% |
| FY2009 | Dec 31, 2009 | $20.36B | +11.3% |
| FY2008 | Dec 31, 2008 | $18.29B | +13.5% |
| FY2007 | Dec 29, 2007 | $16.11B | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $47.23B | +5.2% |
| Q1 FY2026 | Mar 31, 2026 | $44.98B | +3.3% |
| Q4 FY2025 | Dec 31, 2025 | $46.63B | +9.9% |
| Q3 FY2025 | Sep 30, 2025 | $45.83B | +7.9% |
| Q2 FY2025 | Jun 30, 2025 | $44.91B | +8.9% |
| Q1 FY2025 | Mar 31, 2025 | $43.53B | +7.8% |
| Q4 FY2024 | Dec 31, 2024 | $42.44B | +16.6% |
| Q3 FY2024 | Sep 30, 2024 | $42.48B | +21.1% |
| Q2 FY2024 | Jun 30, 2024 | $41.24B | +16.5% |
| Q1 FY2024 | Mar 31, 2024 | $40.36B | +19.3% |
| Q4 FY2023 | Dec 31, 2023 | $36.39B | +13.3% |
| Q3 FY2023 | Sep 30, 2023 | $35.08B | +13.9% |
| Q2 FY2023 | Jun 30, 2023 | $35.39B | +12.9% |
| Q1 FY2023 | Mar 31, 2023 | $33.82B | +8.0% |
| Q4 FY2022 | Dec 31, 2022 | $32.12B | +6.3% |
| Q3 FY2022 | Sep 30, 2022 | $30.79B | +7.0% |
| Q2 FY2022 | Jun 30, 2022 | $31.35B | +7.7% |
| Q1 FY2022 | Mar 31, 2022 | $31.32B | +11.0% |
| Q4 FY2021 | Dec 31, 2021 | $30.23B | +11.5% |
| Q3 FY2021 | Sep 30, 2021 | $28.78B | +10.2% |
| Q2 FY2021 | Jun 30, 2021 | $29.10B | +15.9% |
| Q1 FY2021 | Mar 31, 2021 | $28.20B | +6.8% |
| Q4 FY2020 | Dec 31, 2020 | $27.10B | +9.2% |
| Q3 FY2020 | Sep 30, 2020 | $26.12B | +7.2% |
| Q2 FY2020 | Jun 30, 2020 | $25.10B | +2.6% |
| Q1 FY2020 | Mar 31, 2020 | $26.41B | +8.2% |
| Q4 FY2019 | Dec 31, 2019 | $24.82B | +79.1% |
| Q3 FY2019 | Sep 30, 2019 | $24.37B | +232.6% |
| Q2 FY2019 | Jun 30, 2019 | $24.46B | +239.7% |
| Q1 FY2019 | Mar 31, 2019 | $24.40B | +255.7% |
| Q4 FY2018 | Dec 31, 2018 | $13.86B | +75.4% |
| Q3 FY2018 | Sep 30, 2018 | $7.33B | +3.0% |
| Q2 FY2018 | Jun 30, 2018 | $7.20B | +4.0% |
| Q1 FY2018 | Mar 31, 2018 | $6.86B | +4.4% |
| Q4 FY2017 | Dec 31, 2017 | $7.90B | +3.9% |
| Q3 FY2017 | Sep 30, 2017 | $7.12B | -5.0% |
| Q2 FY2017 | Jun 30, 2017 | $6.93B | – |
| Q1 FY2017 | Mar 31, 2017 | $6.57B | – |
| Q4 FY2016 | Dec 31, 2016 | $7.61B | – |
| Q3 FY2016 | Sep 30, 2016 | $7.49B | – |
See a number that looks wrong?